Imunon, Inc.
NASDAQImunon enters the final stretch before its May 14 Q1 results with an unusually sharp contrast: a freshly initiated Buy rating and a $10 price target from Maxim Group against a stock trading at $2.75 — and a cash runway that runs only into the second half of 2026. The Maxim initiation on April 17 is the dominant event of this week. Analyst Jason McCarthy set a $10 target, implying…
Snapshot as of 10 May 2026
Imunon enters the final stretch before its May 14 Q1 results with an unusually sharp contrast: a freshly initiated Buy rating and a $10 price target from Maxim Group against a stock trading at $2.75 — and a cash runway…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IMNN — free to start on ORTEX.
Sign up for free →Open IMNN on ORTEX